UNTREATED

Clinical trials for UNTREATED explained in plain language.

Never miss a new study

Get alerted when new UNTREATED trials appear

Sign up with your email to follow new studies for UNTREATED, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for pancreatic cancer: drug combo aims to shrink tumors

Disease control Not yet recruiting

This study tests whether adding a hedgehog inhibitor (NLM-001) and two immunotherapy drugs (botensilimab and balstilimab) to standard chemotherapy can shrink tumors better than chemotherapy alone in people with advanced pancreatic cancer that hasn't been treated yet. About 40 adu…

Matched conditions: UNTREATED

Phase: PHASE2 • Sponsor: Nelum Corp • Aim: Disease control

Last updated May 13, 2026 16:02 UTC

UNTREATED

Get alerted when new UNTREATED trials appear

New hope for pancreatic cancer: drug combo aims to shrink tumors